---
title: "(Video) Hims vs Noom vs Ro: Who Will Win the Telemedicine War?"
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39692351.md"
description: "In episode 61 of the “Hims House” podcast, host Jonathan Stern interviewed Geoff Cook, the CEO of Noom. The core content of the video revolves around a major recent move by Noom: the acquisition of the 503A compounding pharmacy, Tailor Made Compounding. This interview delves into the future of the telemedicine industry, regulatory trends for GLP-1 drugs, and the potential of the “healthy aging” market..."
datetime: "2026-04-02T06:27:44.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39692351.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39692351.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39692351.md)
author: "[ST欧阳昆汀(被困Hims版)](https://longbridge.com/en/profiles/4868421.md)"
---

# (Video) Hims vs Noom vs Ro: Who Will Win the Telemedicine War?

Episode 61 of the "Hims House" podcast featured host Jonathan Stern interviewing Geoff Cook, CEO of Noom. The core content of the video revolves around a major recent move by Noom: the acquisition of the 503A compounding pharmacy Tailor Made Compounding. This interview delves into the future of the telemedicine industry, regulatory trends for GLP-1 drugs, and the potential of the "healthy aging" market.$Defiance Daily Target 2X Long HIMS ETF(HIMZ.US) $Hims & Hers Health(HIMS.US)

### Related Stocks

- [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md)
- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)

## Comments (1)

- **小袁边走边吃 · 2026-04-02T07:26:32.000Z**: Is there an AI summary?